Gyre Therapeutics Inc (GYRE)

Precedente Chiudi:

$15.29

Aprire:

$15.18

Volume 24 ore:

63,073

Capitalizzazione di mercato:

$1.22B

Reddito:

-

Utile/perdita netta:

-

Rapporto P/E:

-

EPS:

-

Flusso di cassa netto:

-

1 W Prestazione:

-3.91%

1M Prestazione:

-10.10%

6M Prestazione:

+0.00%

1 anno Prestazione:

+0.00%

Intervallo 1D:

$13.71

$15.18

Portata 52W:

$10.41

$27.10

Gyre Therapeutics Inc Stock (GYRE) Company Profile

Nome

Gyre Therapeutics Inc

Settore

Healthcare (1209)

Industria

Biotechnology (699)

Telefono

650-871-0761

Indirizzo

611 GATEWAY BLVD., SUITE 710, SOUTH SAN FRANCISCO

Dipendente

0

Cinguettio

Prossima data di guadagno

2024-06-12

Ultimi documenti SEC

GYRE's Discussions on Twitter

Gyre Therapeutics Inc Stock (GYRE) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2021-04-29	Ripresa	Stephens	Overweight
2021-02-10	Iniziato	Piper Sandler	Overweight
2020-05-21	Iniziato	Raymond James	Outperform
2019-01-04	Iniziato	Oppenheimer	Outperform
2018-02-12	Reiterato	B. Riley FBR, Inc.	Buy
2018-02-09	Reiterato	Chardan Capital Markets	Buy
2017-12-08	Iniziato	B. Riley FBR, Inc.	Buy
2017-06-12	Iniziato	Chardan Capital Markets	Buy
2017-06-06	Iniziato	Ladenburg Thalmann	Buy
2016-06-30	Iniziato	Rodman & Renshaw	Buy

Mostra tutto

Gyre Therapeutics Inc Borsa (GYRE) Ultime notizie

Gyre Therapeutics Reports First Quarter 2024 Earnings - Yahoo Finance

Yahoo Finance

Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire Inc.

Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update - Investing.com South Africa

Investing.com South Africa

Gyre Therapeutics exec sells shares worth over $282,000 By Investing.com - Investing.com Canada

Investing.com Canada

Public companies among Gyre Therapeutics, Inc.'s (NASDAQ:GYRE) largest shareholders, saw gain in holdings value after stock jumped 10% last week - Simply Wall St

Simply Wall St

Gyre Therapeutics Stock: Under The Radar Biotech Has A Shot At MASH Approval (NASDAQ:GYRE) - Seeking Alpha

Seeking Alpha

Gyre Therapeutics Inc Azioni (GYRE) Dati Finanziari

Gyre Therapeutics Inc Azioni (GYRE) insider trading